18 and older, female only, with Pregnancy, High Risk or Opioid-Related Disorders. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Opioid Use Disorder (OUD) and Other Substance Use Disorder (SUD) Treatment Linkage/RetentionPrimary· 6 months
Percentage of days of days of attending outpatient and inpatient Substance Use Disorder treatment.
Group
Value
95% CI
Control
-1.5
± 50.2
Patient Navigation
-8.8
± 46.7
Adherence to Medication-Assisted Treatment (MAT) Medication Use SectionPrimary· 6 months
Adherence to MAT will be assessed through the treatment services review (TSR-6) medication use section defined by percentage days of attendance.
Group
Value
95% CI
Control
30.7
± 43.8
Patient Navigation
40.4
± 53.6
Adequacy of Prenatal CareSecondary· 1 week
Capturing prenatal care will be accessed through the adequacy of prenatal care utilization index (APNCU). This index will be used to determine the sufficiency of prenatal care participants received.
Group
Value
95% CI
Control
10
Patient Navigation
12
Control
13
Patient Navigation
15
Control
11
Patient Navigation
11
Control
9
Patient Navigation
11
Sponsor's own description
The US opioid epidemic continues to result in serious health consequences for pregnant and postpartum women. In the US from 2007 to 2012, an average of 21,000 pregnant women each year reported past month opioid misuse. This study aims to provide rapid and targeted primary prevention activities aimed at assisting pregnant women with opioid use disorder (OUD) to become linked to and retained in treatment in order to reduce harms to them (including overdose) and their offspring.
Publications & conference data
7 peer-reviewed publications reference this trial (live from Europe PMC):
NCT07332312 — A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Ind
· NA
· not yet recruiting
NCT07176000 — Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington S
· NA
· not yet recruiting
NCT07091617 — Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
· NA
· recruiting
NCT06995924 — Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education
· NA
· recruiting
NCT07052630 — Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in Hematopoieti
· NA
· recruiting
Other recruiting trials for Pregnancy, High Risk
Currently open trials in the same condition.
NCT05388643 — Early Detection of Gestational Diabetes Mellitus in Pregnancy
· NA
· recruiting
NCT06654713 — Commercial or Open Source Closed Loop Impact on Pregnancy Study
· recruiting
NCT05317585 — Continuous Glucose Monitor Use in Pregnancy
· NA
· recruiting
NCT05790252 — Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)
· Phase 3
· recruiting
NCT05909046 — A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
· NA
· recruiting
Other University of Utah trials
Trials by the same sponsor.
NCT07515755 — Supplemental Oxygen and Oxygen Desaturations in Colonoscopies
· NA
· not yet recruiting
NCT07225426 — Personalizing Financial Incentives
· NA
· recruiting
NCT06716411 — Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness
· NA
· recruiting
NCT07246538 — Positive Airway Pressure (PAP) System Evaluation in Volunteers
· NA
· not yet recruiting
NCT04208984 — Diversion Device With Breath Control
· withdrawn
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Utah
Last refreshed: 3 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03833245.